| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | 1.642 | 9.517 | 6.322 | 6.202 | 4.508 | 2.985 | 0 | 0 |
| Total Income - EUR | - | - | 1.642 | 10.083 | 6.874 | 6.259 | 4.508 | 2.985 | 0 | 0 |
| Total Expenses - EUR | - | - | 47 | 699 | 4.393 | 1.215 | 2.539 | 3.100 | 373 | 0 |
| Gross Profit/Loss - EUR | - | - | 1.595 | 9.384 | 2.481 | 5.044 | 1.969 | -116 | -373 | 0 |
| Net Profit/Loss - EUR | - | - | 1.546 | 9.082 | 2.274 | 4.867 | 1.837 | -145 | -373 | 0 |
| Employees | - | - | 0 | 0 | 1 | 0 | 1 | 1 | 0 | 0 |
Check the financial reports for the company - Epidemiological Cdc Medical Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | 37 | 39 | 23 | 7 | 56.006 | 56.167 | 55.997 | 0 |
| Current Assets | - | - | 1.679 | 10.748 | 13.006 | 17.378 | 21.818 | 21.138 | 18.294 | 18.562 |
| Inventories | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | 0 | 1.931 | 0 | 2 | 18 | 0 | 5.661 | 5.729 |
| Cash | - | - | 1.679 | 8.817 | 13.006 | 17.375 | 21.800 | 21.138 | 12.633 | 12.833 |
| Shareholders Funds | - | - | 1.590 | 10.643 | 12.711 | 17.337 | 18.789 | 18.702 | 18.273 | 18.563 |
| Social Capital | - | - | 44 | 43 | 42 | 41 | 81 | 81 | 81 | 80 |
| Debts | - | - | 126 | 145 | 318 | 48 | 59.035 | 58.603 | 56.018 | 0 |
| Income in Advance | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8610 - 8610" | |||||||||
| CAEN Financial Year |
8610
|
|||||||||
Comments - Epidemiological Cdc Medical Srl